Altered Expression of 14-3-3ζ Protein in Spinal Cords of Rat Fetuses with Spina Bifida Aperta

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Wu, Li Na ^a   Wei, Xiao wei ^a   Fan, Yang ^a   Miao, Jia Ning ^a   Wang, Li Li ^a   Zhang, Yi ^a   Wu, Di ^a   Yuan, Zheng Wei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 375; MICRORNA 451; MICRORNA 7; PROTEIN 14 3 3; PROTEIN 14 3 3 ZETA; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EMBRYO DEVELOPMENT; FETUS; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; NEURAL TUBE DEFECT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINA BIFIDA APERTA; SPINAL CORD; SPINAL DYSRAPHISM;

14-3-3 PROTEINS; ANIMALS; APOPTOSIS; DOWN-REGULATION; FEMALE; FETUS; GENE EXPRESSION REGULATION; MALE; MICRORNAS; PREGNANCY; RATS; SPINA BIFIDA CYSTICA; SPINAL CORD; TRETINOIN; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84881129430     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070457     Document Type: Article

References (62)

1. Date I, Yagyu Y, Asari S, Ohmoto T, (1993) Long-term outcome in surgically treated spina bifida cystica. Surg Neurol 40: 471-475.
2. Drewek MJ, Bruner JP, Whetsell WO, Tulipan N, (1997) Quantitative analysis of the toxicity of human amniotic fluid to cultured rat spinal cord. Pediatr Neurosurg 27: 190-193.
3. Correia-Pinto J, Reis JL, Hutchins GM, Baptista MJ, Estevão-Costa J, et al. (2002) In utero meconium exposure increases spinal cord necrosis in a rat model of myelomeningocele. J Pediatr Surg 37: 488-492.
4. Yuan ZW, Lui VC, Tam PK, (2003) Deficient motor innervation of the sphincter mechanism in fetal rats with anorectal malformation: a quantitative study by fluorogold retrograde tracing. J Pediatr Surg 38: 1383-1388.
5. Guan K, Li H, Fan Y, Wang W, Yuan ZW, (2009) Defective development of sensory neurons innervating the levator ani muscle in fetal rats with anorectal malformation. Birth Defects Res A Clin Mol Teratol 85: 583-587.
6. Zhao JJ, Sun DG, Wang J, Liu SR, Zhang CY, et al. (2008) Retinoic acid downregulates microRNAs to induce abnormal development of spinal cord in spina bifida rat model. Childs Nerv Syst 24: 485-492.
7. Wei X, Li H, Miao J, Zhou F, Liu B, et al. (2012) Disturbed apoptosis and cell proliferation in developing neuroepithelium of lumbo-sacral neural tubes in retinoic acid-induced spina bifida aperta in rat. Int J Dev Neurosci 30: 375-381.
8. Fan Y, Wang L, Zhou F, Zhang Y, Li H, et al. (2011) Comparative proteomics of spinal cords of rat fetuses with spina bifida aperta. J Proteomics 75: 668-676.
9. Cao W, Yang X, Zhou J, Teng Z, Cao L, et al. (2010) Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice. Apoptosis 15: 230-241.
10. Matta A, DeSouza LV, Ralhan R, Siu KW, (2010) Small interfering RNA targeting 14-3-3ζ increases efficacy of chemotherapeutic agents in head and neck cancer cells. Mol cancer Ther 9: 2676-2688.
11. Li Z, Zhao J, Du Y, Park HR, Sun SY, et al. (2008) Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci U S A 105: 162-167.
12. Sari Y, Zhang M, Mechref Y, (2010) Differential expression of proteins in fetal brains of alcohol-treated prenatally C57BL/6 mice: a proteomic investigation. Electrophoresis 31: 483-496.
13. Shirakashi Y, Kawamoto Y, Tomimoto H, Takahashi R, Ihara M, (2006) α-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice. Acta Neuropathol 112: 681-689.
14. Lu ZJ, Liu SY, Yao YQ, Zhou YJ, Zhang S, et al. (2011) The effect of miR-7 on behavior and global protein expression in glioma cell lines. Electrophoresis 32: 3612-3620.
15. Yang MY, Lin PM, Liu YC, Hsiao HH, Yang WC, et al. (2012) Induction of cellular senescence by doxorubicin is associated with upregulated miR-375 and induction of autophagy in K562 cells. PLoS One 7: e37205.
16. Patrick DM, Zhang CC, Tao Y, Yao H, Qi X, et al. (2010) Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta. Genes Dev 24: 1614-1619.
17. Yu D, dos Santos CO, Zhao G, Jiang J, Amigo JD, et al. (2010) miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev 24: 1620-1633.
18. Datta SR, Katsov A, Hu L, Petros A, Fesik SW, et al. (2000) 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6: 41-51.
19. Nomura M, Shimizu S, Sugiyama T, Narita M, Ito T, et al. (2003) 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem 278: 2058-2065.
20. Dobson M, Ramakrishnan G, Ma S, Kaplun L, Balan V, et al. (2011) Bimodal regulation of FoxO3 by AKT and 14-3-3. Biochim Biophys Acta 1813: 1453-1464.
21. Obsil T, Ghirlando R, Anderson DE, Hickman AB, Dyda F, (2003) Two 14-3-3 binding motifs are required for stable association of forkhead transcription factor FOXO4 with 14-3-3 proteins and inhibition of DNA binding. Biochemistry 42: 15264-15272.
22. Silhan J, Vacha P, Strnadova P, Vecer J, Herman P, et al. (2009) 14-3-3 protein masks the DNA binding interface of forkhead transcription factor FOXO4. J Biol Chem 284: 19349-19360.
23. Vincenz C, Dixit VM, (1996) 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J Biol Chem 271: 20029-20034.
24. Lee JA, Park JE, Lee DH, Park SG, Myung PK, et al. (2008) G1 to S phase transition protein 1 induces apoptosis signal-regulating kinase 1 activation by dissociating 14-3-3 from ASK1. Oncogene 27: 1297-1305.
25. Grossmann J, (2002) Molecular mechanisms of "detachment-induced apoptosis-Anoikis.". Apoptosis 7: 247-260.
26. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, et al. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
27. Danes CG, Wyszomierski SL, Lu J, Neal CL, Yang W, et al. (2008) 14-3-3ζ downregulates p53 in mammary epithelial cells and confers luminal filling. Cancer Res 68: 1760-1767.
28. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, et al. (2010) Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88: 1008-1016.
29. Xiao KZ, Zhang ZY, Su YM, Liu FQ, Yan ZZ, et al. (1990) Central nervous system congenital malformations, especially neural tube defects in 29 provinces, metropolitan cities and autonomous regions of China: Chinese Birth Defects Monitoring Program. Int J Epidemiol 19: 978-982.
30. Diez-Pardo JA, Mariño JM, Baoquan Q, Delgado-Baeza E, Fernáneez A, et al. (1995) neural tube defects: an experimental model in the foetal rat. Eur J Pediatr Surg 5: 198-202.
31. Fu H, Subramanian RR, Masters SC, (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40: 617-647.
32. Tzivion G, Shen YH, Zhu J, (2001) 14-3-3 proteins;bringing new definitions to scaffolding. Oncogene 20: 6331-6338.
33. Aitken A, (2006) 14-3-3 proteins: a historic overview. Semin Cancer Biol 16: 162-172.
34. Kleppe R, Martinez A, Doskeland SO, Haavik J, (2011) The 14-3-3 proteins in regulation of cellular metabolism. Semin Cell Dev Biol 22: 713-719.
35. Berg D, Holzmann C, Riess O, (2003) 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4: 752-762.
36. Liu Y, Tian RF, Li YM, Liu WP, Cao L, et al. (2010) The expression of seven 14-3-3 isoforms in human meningioma. Brain Res 1336: 98-102.
37. MacKay RK, Colson NJ, Dodd PR, Lewohl JM, (2011) Differential expression of 14-3-3 isoforms in human alcoholic brain. Alcohol Clin Exp Res 35: 1041-1049.
38. Harris MN, Ozpolat B, Abdi F, Gu S, Legler A, et al. (2004) Comparative proteomic analysis of all-trans-retinoic acid treatment reveals systematic posttranscriptional control mechanisms in acute promyelocytic leukemia. Blood 104: 1314-1323.
39. Kitao Y, Robertson B, Kudo M, Grant G, (2002) Proliferation patterns of dorsal root ganglion neurons of cutaneous, muscle and visceral nerves in the rat. J Neurocytol 31: 765-776.
40. Mirnics K, Koerber HR, (1995) Prenatal development of rat primary afferent fibers: I. Peripheral projections. J Comp Neurol 355: 589-600.
41. Kawamoto S, Iemura N, Inoue Y, Katakura Y, Shirahata S, (2000) Effect of 14-3-3 protein induction on cell proliferation of A549 human lung adenocarcinoma. Cytotechnology 33: 253-257.
42. Liang S, Singh M, Gam LH, (2010) The differential expression of aqueous soluble proteins in breast normal and cancerous tissues in relation to stage and grade of patients. J Biomed Biotechnol 2010: 516469.
43. Bergamaschi A, Christensen BL, Katzenellenbogen BS, (2011) Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis. Breast Cancer Res 13: R70.
44. Wang Y, Meriin AB, Zaarur N, Romanova NV, Chernoff YO, et al. (2009) Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J 23: 451-63.
45. Morrison DK, (2009) The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 19: 16-23.
46. Porter GW, Khuri FR, Fu H, (2006) Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin Cancer Biol 16: 193-202.
47. Hermeking H, (2003) The 14-3-3 cancer connection. Nat Rev Cancer 3: 931-943.
48. Dong S, Kang S, Gu TL, Kardar S, Fu H, et al. (2007) 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells. Blood 110: 360-369.
49. Zhou J, Shao Z, Kerkela R, Ichijo H, Muslin AJ, et al. (2009) Serine 58 of 14-3-3 zeta is a molecular switch regulating ASK1 and oxidant stress-induced cell death. Mol Cell Biol 29: 4167-4176.
50. Heyninck K, Van Huffel S, Kreike M, Beyaert R, (2004) Yeast two-hybrid screening for proteins interacting with the anti-apoptotic protein A20. Methods Mol Biol 282: 223-241.
51. Liang SH, Clarke MF, (2001) Regulation of p53 localization. Eur J Biochem 268: 2779-2783.
52. Brooks CL, Gu W, (2006) p53 ubiquitination: Mdm2 and beyond. Mol Cell 21: 307-315.
53. O'Brate A, Giannakakou P, (2003) The importance of p53 location: nuclear or cytoplasmic zip code? Drug Resist Updat 6: 313-322.
54. Lai EC, (2002) MicroRNAs are complementary to 3′ UTR sequence motifs that mediate negativepost-transcriptional regulation. Nat Genet 30: 363-364.
55. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355.
56. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
57. Stefani G, Slack FJ, (2008) Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219-230.
58. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, et al. (2008) microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68: 3566-3572.
59. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, et al. (2010) MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70: 2339-2349.
60. Zhang Z, Luo X, Ding S, Chen J, Chen T, et al. (2012) MicroRNA-451 regulates p38 MAPK signaling by targeting of Ywhaz and suppresses the mesangial hypertrophy in early diabetic nephropathy. FEBS Lett 586: 20-26.
61. Bergamaschi A, Katzenellenbogen BS, (2012) Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance. Oncogene 31: 39-47.
62. Li H, Gao F, Ma L, Jiang J, Miao J, et al. (2012) Therapeutic potential of in utero mesenchymal stem cell (MSCs) transplantation in rat foetuses with spina bifida aperta. J Cell Mol Med 16: 1606-1617.